Jeff Ubben's activist firm ValueAct Capital has made a few notable transactions recently.
ValueAct Boosts KKR Stake
First, ValueAct has filed a 13D with the SEC regarding its stake in KKR (KKR). Per the filing, ValueAct now owns 9.99% of the private equity firm with 47.75 million shares.
Per the filing, ValueAct was buying KKR shares throughout mid-to-late November. They bought between $19.19 and $19.50 and in total acquired 2.19 million shares.
You can view the rest of ValueAct's portfolio here.
Per Google Finance, KKR is "a global investment firm that manages multiple alternative asset classes, including private equity, energy, infrastructure, real estate, credit, and, through its strategic partners, hedge funds."
Ubben's Firm Sells More CBRE Group
Second, in a series of Form 4's filed with the SEC, ValueAct has disclosed a sale of over 3 million shares of CBRE Group (CBG). They sold 2.3 million shares at $42.25 on November 28th, sold another 600,000 at $42.57 on November 27th, and sold 246,000 on November 22nd. After all these sales they still own over 24.91 million shares.
Per Google Finance, CBRE Group is "CBRE Group, Inc. is the largest commercial real estate services and investment firm in the world. It is based in Los Angeles, California and operates more than 450 offices worldwide and has clients in more than 100 countries."
You can view the rest of ValueAct's portfolio here.
Friday, December 1, 2017
ValueAct Capital Boosts KKR Stake, Trims CBRE Group
Labels:
13d,
activist investing,
CBG,
form4,
hedge fund portfolios,
jeffrey ubben,
KKR,
SEC filing,
valueact
blog comments powered by Disqus